UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 94

Sortiert nach

C-reactive protein as robust laboratory value associated with prognosis in patients with stage III non-small cell lung cancer (NSCLC) treated with definitive radiochemotherapy

Scientific reports, 2024-06, Vol.14 (1), p.13765-12, Article 13765

2024

Link zum Volltext

Verfügbarkeit prüfen

Prediction of malignant lymph nodes in NSCLC by machine-learning classifiers using EBUS-TBNA and PET/CT

Scientific reports, 2022-10, Vol.12 (1), p.17511-17511, Article 17511

2022

Link zum Volltext

Verfügbarkeit prüfen

Impact of metallothionein-knockdown on cisplatin resistance in malignant pleural mesothelioma

Scientific reports, 2020-10, Vol.10 (1), p.18677, Article 18677

2020

Link zum Volltext

Verfügbarkeit prüfen

DNA methylation of PTGER4 in peripheral blood plasma helps to distinguish between lung cancer, benign pulmonary nodules and chronic obstructive pulmonary disease patients

European journal of cancer (1990), 2021-04, Vol.147, p.142-150

2021

Link zum Volltext

Verfügbarkeit prüfen

Gene expression profiling of homologous recombination repair pathway indicates susceptibility for olaparib treatment in malignant pleural mesothelioma in vitro

BMC cancer, 2019-01, Vol.19 (1), p.108-12, Article 108

2019

Link zum Volltext

Verfügbarkeit prüfen

Machine learning reveals a PD-L1–independent prediction of response to immunotherapy of non-small cell lung cancer by gene expression context

European journal of cancer (1990), 2020-11, Vol.140, p.76-85

2020

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant and adjuvant end-points in health technology assessment in oncology

European journal of cancer (1990), 2021-04, Vol.147, p.40-50

2021

Link zum Volltext

Verfügbarkeit prüfen

Long-term survival of patients with central or > 7 cm T4 N0/1 M0 non-small-cell lung cancer treated with definitive concurrent radiochemotherapy in comparison to trimodality treatment

Radiation oncology (London, England), 2022-07, Vol.17 (1), p.1-126, Article 126

2022

Link zum Volltext

Verfügbarkeit prüfen

Treatment decisions, clinical outcomes, and pharmacoeconomics in the treatment of patients with EGFR mutated stage III/IV NSCLC in Germany: an observational study

BMC cancer, 2018-02, Vol.18 (1), p.135-135, Article 135

2018

Link zum Volltext

Verfügbarkeit prüfen

68Ga-SSO-120 PET for Initial Staging of Small Cell Lung Cancer Patients: A Single-Center Retrospective Study

The Journal of nuclear medicine (1978), 2023-10, Vol.64 (10), p.1540-1549

2023

Link zum Volltext

Verfügbarkeit prüfen

MET Expression in Advanced Non–Small-Cell Lung Cancer: Effect on Clinical Outcomes of Chemotherapy, Targeted Therapy, and Immunotherapy

Clinical lung cancer, 2018-07, Vol.19 (4), p.e441-e463

2018

Link zum Volltext

Verfügbarkeit prüfen

The IASLC Lung Cancer Staging Project: Proposals for the Revision of the M Descriptors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer

Journal of thoracic oncology, 2015-11, Vol.10 (11), p.1515-1522

2015

Link zum Volltext

Verfügbarkeit prüfen

History Can Teach Us Something: Angiogenesis Inhibition Revisited

Journal of thoracic oncology, 2024-06, Vol.19 (6), p.849-851

2024

Link zum Volltext

Verfügbarkeit prüfen

Patterns of nodal spread in stage III NSCLC: importance of EBUS-TBNA and 18F-FDG PET/CT for radiotherapy target volume definition

Radiation oncology (London, England), 2021-09, Vol.16 (1), p.1-176, Article 176

2021

Link zum Volltext

Verfügbarkeit prüfen

Inhibiting the Aurora B Kinase Potently Suppresses Repopulation During Fractionated Irradiation of Human Lung Cancer Cell Lines

International journal of radiation oncology, biology, physics, 2012-10, Vol.84 (2), p.492-499

2012

Link zum Volltext

Verfügbarkeit prüfen

Too Good to be True?

Journal of thoracic oncology, 2021-04, Vol.16 (4), p.507-508

2021

Link zum Volltext

Verfügbarkeit prüfen

N-staging in large cell neuroendocrine carcinoma of the lung: diagnostic value of [18F]FDG PET/CT compared to the histopathology reference standard

EJNMMI research, 2021-07, Vol.11 (1), p.68-68, Article 68

2021

Link zum Volltext

Verfügbarkeit prüfen

Neutrophils Activate Tumoral CORTACTIN to Enhance Progression of Orohypopharynx Carcinoma

Frontiers in immunology, 2013-01, Vol.4, p.33-33

2013

Link zum Volltext

Verfügbarkeit prüfen

High Prevalence of Concomitant Oncogene Mutations in Prospectively Identified Patients with ROS1-Positive Metastatic Lung Cancer

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.54-64

2017

Link zum Volltext

Verfügbarkeit prüfen

A Novel Epitope Quality-Based Immune Escape Mechanism Reveals Patient's Suitability for Immune Checkpoint Inhibition

Cancer management and research, 2020-01, Vol.12, p.7881-7890

2020

Link zum Volltext

Verfügbarkeit prüfen

Aktueller Stand der Diagnostik und Therapie des nichtkleinzelligen Lungenkarzinoms (NSCLC) im Stadium III

Der Onkologe, 2018-12, Vol.24 (12), p.974-982

2018

Link zum Volltext

Verfügbarkeit prüfen

Multimodal treatment of non-small-cell lung cancer

The Lancet (British edition), 2015-09, Vol.386 (9998), p.1018-1020

2015

Link zum Volltext

Verfügbarkeit prüfen

Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage III non–small-cell lung cancer

The Journal of thoracic and cardiovascular surgery, 2010-06, Vol.139 (6), p.1424-1430

2010

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 94

Suche als RSS-Feed

Aktive Filter

ThemaLung Neoplasms - Drug Therapy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(89)
Mit Volltextzugriff
(91)

Publikationsform

Artikel
(93)
Tagungsberichte
(1)

Sprache

Englisch
(90)
Japanisch
(17)
Deutsch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(67)
Life Sciences & Biomedicine
(65)
Oncology
(59)
Humans
(49)
Respiratory System
(31)
Lung Cancer
(30)
Lung Neoplasms - Pathology
(29)
Female
(23)
Male
(23)
Neoplasm Staging
(23)
Prognosis
(20)
Carcinoma, Non-Small-Cell Lung - Pathology
(18)
Aged
(17)
Middle Aged
(17)
Tumors
(17)
Adult
(13)
Lung Neoplasms - Therapy
(12)
Cancer
(11)
Lung Neoplasms - Classification
(11)
Biological And Medical Sciences
(10)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

C-reactive protein as robust laboratory value associated with prognosis in patients with stage III non-small cell lung cancer (NSCLC) treated with definitive radiochemotherapy

Prediction of malignant lymph nodes in NSCLC by machine-learning classifiers using EBUS-TBNA and PET/CT

Impact of metallothionein-knockdown on cisplatin resistance in malignant pleural mesothelioma

DNA methylation of PTGER4 in peripheral blood plasma helps to distinguish between lung cancer, benign pulmonary nodules and chronic obstructive pulmonary disease patients

Gene expression profiling of homologous recombination repair pathway indicates susceptibility for olaparib treatment in malignant pleural mesothelioma in vitro

Machine learning reveals a PD-L1–independent prediction of response to immunotherapy of non-small cell lung cancer by gene expression context

Neoadjuvant and adjuvant end-points in health technology assessment in oncology

Long-Term Survival in Patients with Oligometastatic Non-Small Cell Lung Cancer by a Multimodality Treatment-Comparison with Stage III Disease

Long-term survival of patients with central or > 7 cm T4 N0/1 M0 non-small-cell lung cancer treated with definitive concurrent radiochemotherapy in comparison to trimodality treatment

Treatment decisions, clinical outcomes, and pharmacoeconomics in the treatment of patients with EGFR mutated stage III/IV NSCLC in Germany: an observational study

68Ga-SSO-120 PET for Initial Staging of Small Cell Lung Cancer Patients: A Single-Center Retrospective Study

MET Expression in Advanced Non–Small-Cell Lung Cancer: Effect on Clinical Outcomes of Chemotherapy, Targeted Therapy, and Immunotherapy

The IASLC Lung Cancer Staging Project: Proposals for the Revision of the M Descriptors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer

History Can Teach Us Something: Angiogenesis Inhibition Revisited

Patterns of nodal spread in stage III NSCLC: importance of EBUS-TBNA and 18F-FDG PET/CT for radiotherapy target volume definition

Inhibiting the Aurora B Kinase Potently Suppresses Repopulation During Fractionated Irradiation of Human Lung Cancer Cell Lines

Too Good to be True?

KRAS G12C-mutated advanced non-small cell lung cancer: A real-world cohort from the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315)

N-staging in large cell neuroendocrine carcinoma of the lung: diagnostic value of [18F]FDG PET/CT compared to the histopathology reference standard

Neutrophils Activate Tumoral CORTACTIN to Enhance Progression of Orohypopharynx Carcinoma

High Prevalence of Concomitant Oncogene Mutations in Prospectively Identified Patients with ROS1-Positive Metastatic Lung Cancer

A Novel Epitope Quality-Based Immune Escape Mechanism Reveals Patient's Suitability for Immune Checkpoint Inhibition

Aktueller Stand der Diagnostik und Therapie des nichtkleinzelligen Lungenkarzinoms (NSCLC) im Stadium III

Multimodal treatment of non-small-cell lung cancer

Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage III non–small-cell lung cancer

Aktive Filter

Suchergebnisse filtern